Graham K. Crooke
Director/Board Member at Sonoma Orthopedic Products, Inc.
Profile
Graham K.
Crooke is the founder of Helix Ventures LLC, which was founded in 2008.
He was also a Product Manager at Molecular Devices LLC and a Vice President at Dillon, Read & Co., Inc. and Dillon Read Capital Management.
Dr. Crooke earned a doctorate from The University of Western Australia in 1983 and an MBA from Stanford Graduate School of Business in 1988.
Graham K. Crooke active positions
| Companies | Position | Start |
|---|---|---|
Koronis Pharmaceuticals, Inc.
 Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Director/Board Member | - |
Sonoma Orthopedic Products, Inc.
 Sonoma Orthopedic Products, Inc. Medical SpecialtiesHealth Technology Sonoma Orthopedic Products, Inc. develops and manufactures orthopedic devices. The company was founded by Stephen D. Guntherand and Charles L. Nelson in 2005 and is headquartered in Buffalo Grove, IL. | Director/Board Member | - |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Director/Board Member | 1999-12-31 |
Biomimedica, Inc.
 Biomimedica, Inc. Medical SpecialtiesHealth Technology Biomimedica, Inc. develops medical devices to restore damaged joints. Its main focus is to treat degenerative disease of articular cartilage, which is called Osteoarthritis. The company was founded by David Myung and Lampros Kourtis in 2008 and is headquartered in Ripon, CA. | Director/Board Member | - |
Valence Investments SPV IV LLC
 Valence Investments SPV IV LLC BiotechnologyHealth Technology Valence Investments SPV IV LLC engages in the provision of biotechnology services. The company is headquartered in New York, NY. | Director/Board Member | - |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Private Equity Investor | - |
Former positions of Graham K. Crooke
| Companies | Position | End |
|---|---|---|
Helix Ventures LLC
 Helix Ventures LLC Investment ManagersFinance Helix Ventures LLC (Helix Ventures) is a venture capital firm founded in 2008 by Graham Crooke, Philip Sawyer and Evgeny Zaytsev. The firm is headquartered in Palo Alto, California. | Founder | 2020-12-30 |
| COHERUS BIOSCIENCES, INC. | Director/Board Member | 2014-05-18 |
| INSMED INCORPORATED | Director/Board Member | 2010-11-30 |
| ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Graham K. Crooke
| The University of Western Australia | Doctorate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| CHIMERIX, INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| Private companies | 15 |
|---|---|
Sonoma Orthopedic Products, Inc.
Sonoma Orthopedic Products, Inc. Medical SpecialtiesHealth Technology Sonoma Orthopedic Products, Inc. develops and manufactures orthopedic devices. The company was founded by Stephen D. Guntherand and Charles L. Nelson in 2005 and is headquartered in Buffalo Grove, IL. | Health Technology |
Angiogenix, Inc.
 Angiogenix, Inc. Pharmaceuticals: MajorHealth Technology Angiogenix, Inc. develops therapeutic solutions for chronic vascular disease. Its products help the body produce new blood vessels to increase blood flow. The company's product ACCLAIM treats chronic ischemia (lack of oxygen in the heart muscle). Angx1039 is being developed to treat peripheral vascular disease (a narrowing of the vessels carrying blood to the legs, arms and internal organs) and Angx3227 targets sickle cell disease (an inherited disorder that affects the shape of red blood cells). Its fourth product, Vasotrophin increases blood vessel density. The company is headquartered at Burlingame, CA | Health Technology |
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Health Technology |
INSMED Pharmaceuticals, Inc.
 INSMED Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology INSMED Pharmaceuticals, Inc. develops products for the diagnosis and treatment of conditions associated with insulin resistance. The company is headquartered in Richmond, VA. | Health Technology |
TPE Boulder, Inc.
 TPE Boulder, Inc. Investment ManagersFinance TPE Boulder, Inc. (Ticonderoga Capital) is a private equity firm founded by James Vandervelden in 1997. The firm is headquartered in Braintree, Massachusetts. | Finance |
Dillon Read Capital Management
 Dillon Read Capital Management Investment ManagersFinance Dillon Read Capital Management is a New York City-based hedge fund boutique subsidiary of UBS Global Asset Management (Americas), Inc., itself a division of UBS AG (NYSE: UBS). | Finance |
Molecular Devices LLC
 Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | Health Technology |
Asset Management Co.
 Asset Management Co. Investment ManagersFinance Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA. | Finance |
Helix Ventures LLC
Helix Ventures LLC Investment ManagersFinance Helix Ventures LLC (Helix Ventures) is a venture capital firm founded in 2008 by Graham Crooke, Philip Sawyer and Evgeny Zaytsev. The firm is headquartered in Palo Alto, California. | Finance |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
iScience Interventional Corp.
 iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |
Biomimedica, Inc.
Biomimedica, Inc. Medical SpecialtiesHealth Technology Biomimedica, Inc. develops medical devices to restore damaged joints. Its main focus is to treat degenerative disease of articular cartilage, which is called Osteoarthritis. The company was founded by David Myung and Lampros Kourtis in 2008 and is headquartered in Ripon, CA. | Health Technology |
Valence Investments SPV IV LLC
Valence Investments SPV IV LLC BiotechnologyHealth Technology Valence Investments SPV IV LLC engages in the provision of biotechnology services. The company is headquartered in New York, NY. | Health Technology |
| Dillon, Read & Co., Inc. | Finance |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Finance |
- Stock Market
- Insiders
- Graham K. Crooke